Periodontitis Clinical Trial
Official title:
Treatment of Periodontal Disease in Patients With Acute Myocardial Infarction: Randomized Controlled Trial
The main objective of this study is to evaluate the effect of treatment periodontal endothelium-dependent artery of the arm in patients with acute myocardial infarction with ST-segment elevation undergoing primary coronary intervention.
The present work sample will be composed by individuals who suffered from ST segment
elevation myocardial infarction admitted to the Cardiologic Institute from Porto Alegre.
Participants period of selection and evaluation extended from August 20th, 2012 to January
2015. The whole selection was performed by the responsible researcher, assessing periodontal
condition of the individuals in the hospital bed. The participants will be accompanied
during the hospital stay and outpatient basis, an expected average of six months.
Clinical Exam
Patients selected for the test group will receive periodontal examination in private
offices. For the clinical exam, odontoscopy (Duflex®, Brasil) and Flórida 10mm periodontal
catheters measured in millimeters (Newmar®, Brasil) will be employed. The clinical exam will
be performed by an experienced periodontist (the same one who will perform the patients'
treatment) and will include the evaluation of parameters related to the periodontal disease,
which were noted by an assistant, in a standard form (Attachment A). All permanent teeth
will be examined, except for the third molars. Periodontal variables will be evaluated in
four sites per tooth (vestibular, distal, lingual and mesial), according to the following:
- Visible plaque index (VPI) - dental surfaces will be assessed by the naked eye after
compressed air drying. Codes: 0 = absence of visible plaque, and 1 = presence of
visible plaque (AINAMO and BAY, 1975).
- Catheterization Depth (CD) - distance from the gingival edge to the most apical portion
able to be catheterized, in millimeters.
- Bleeding during Catheterization (BC): It will be registered the presence (score 1) or
absence (score 0) of bleeding 30 seconds after measuring the catheterization depth
- Loss of Insertion (LI): It will be calculated through the distance between the
amelocemental junction to the most apical portion of the periodontal pocket. This
measurement will be performed in millimeters and always rounded down to the lowest
mark.
Endothelial Function Exam Endothelial function assessment will be performed through
endothelial dependent dilation of the brachial artery, observed through ultrasound with a
linear 3-12 MHz transducer (EnVisor CHD, Philips, Bothell, WA, USA). Automated measurements
of the vase diameter will be performed with a software from the equipment used in the
procedure. The evaluations will be performed in the morning period, after an 8-hour fast, in
controlled temperature (22°C). After ten minutes of rest, the images of the brachial artery
will be recorded with a linear transducer continuously placed over the antecubital fossa for
one minute (basal). The sphygmomanometer will be placed in the arm and insufflated to the
edge of 50mmHG above systolic arterial pressure for five minutes, and the alteration in the
diameter of the brachial artery 60 seconds after the cuff deflation will be compared to the
basal diameter. The images of the vase in the end of the diastole (identified by the R wave
in the ECG) will be digitalized and recorded in 3 second gaps during the whole procedure,
being subsequently analyzed offline, using the software of the equipment used in the
procedure.
After 10 minutes of rest, new measurements will be performed, measuring the endothelial
dependent dilation through the administration of 25mg sublingual nytroglycerin. The flow
measuring will be performed with a Doppler wave pulse at an angle of 70o. The increase in
the blood flow after the arterial pressure liberation from the cuff will be expressed as
reflex hyperemia (value for reflex hyperemia, divided by the baseline value for blood flow
in the forearm). After one hundred and eighty days (6 months) a new Endothelial function
assessment will be performed.
Periodontal Treatment Periodontal treatment will be performed by an expert in periodontics,
in a private office, in the following treatment order. First, the case will be presented to
the patients, providing information about periodontal diseases etiopathogeny, focusing on
the importance of bacterial supragingival biofilm control for the treatment success.
Afterwards, all the plaque retentive factors (dental calculus) will be removed in a single
session. Decay lesions will be restored with provisional material; radicular debris will be
extracted, and badly adapted restoration will be adjusted. Supragingival calculus will be
removed with periodontal Gracey curettes (Newmar®, São Paulo, Brasil), followed by
supragingival smoothing and polishing with rubber cup, prophylactic paste, dental floss
and/or interdental brush. In the same session, participants will receive instructions on
personalized oral hygiene, with multibristle brushes, toothpaste, dental floss and
interdental brushes.
Fourteen days after the first appointment, under gingival radicular scraping and smoothing
will be initiated (UGSS) with periodontal files and curettes (Newmar®, São Paulo, Brasil),
under local anaesthesia, for a maximum period of four weeks. By the end of each UGSS
appointment, patients will receive professional plaque removal and oral hygiene
reinforcement, according to individual needs, for motivation and effective behavior change
regarding to oral health care.
After periodontal treatment, patients from the test group will receive clinical reassessment
after ninety days for hygiene reinforcement and professional teeth plaque removal. After one
hundred and eighty days (6 months) a new complete periodontal exam will be performed.
Sample Calculation Minimum sample size will be calculated in 88 patients to detect a flow
mediated dilation difference of 1% between the two study groups, with an average standard
deviation of 1,67%, for a p<0,05 and statistical power of 90%.
Randomization Patients will be selected and invited to participate during hospital
admission. Randomization will be performed two weeks after hospital discharge. Patients will
be randomly distributed through the use of a computer generated table (randomization.com),
to receive periodontal treatment (test group) or to participate in the control group, which
will not receive any clinical intervention during the experiment period, but will be
referred to periodontal treatment after the experimental period.
Blinding Endothelial disfunction evaluation will be performed by a professional that won't
be aware of group allocation of each patient (test or control), either in the begging or end
of the study.
Statistical Analysis Data will be presented as means and standard deviation, with confidence
intervals of 95%, and relative and absolute frequencies. All the analysis will be based on
the intention to treat principle. t Student test for impaired samples will be used to
compare periodontal exam values before and after treatment. General estimative equations
method, followed by multiple comparisons with bonferroni correction will be used to compare
the DMF percentage intra and intergroup (intervention x control), and the covariance
analysis will be used to compare the DMF variation (before and after treatment delta)
between the control and intervention group, adjusted to the initial values. All data will be
analyzed by SPSS software, version 22, and the significance value considered in the analysis
of 0,05.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04712630 -
Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft
|
N/A | |
Completed |
NCT06127069 -
Treatment of Residual Pockets in Periodontal Patients Using an Oscillating Chitosan Device
|
N/A | |
Completed |
NCT04964167 -
Indocyanine-green Mediated Photosensitizer VS Aloe Vera Gel: Adjunct Therapy to Scaling and Root Planing in Patients With Chronic Periodontitis
|
Phase 4 | |
Completed |
NCT05906797 -
Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Periodontitis.
|
N/A | |
Recruiting |
NCT03997552 -
NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration
|
N/A | |
Completed |
NCT05530252 -
Effects of AMP Application After Non-surgical Periodontal Therapy on Treatment of Periodontitis
|
Phase 4 | |
Completed |
NCT04881357 -
Antiplaque/Antigingivitis Effect of Lacer Oros Integral
|
N/A | |
Recruiting |
NCT03790605 -
A Clinical Trial to Study the Effect of a Drug, Curcumin in Patients With Periodontitis
|
Phase 3 | |
Enrolling by invitation |
NCT04971174 -
Outcomes of Periodontal Regenerative Treatment
|
||
Not yet recruiting |
NCT05568290 -
Interleukin-38 Levels in Individuals With Periodontitis
|
||
Completed |
NCT04383561 -
Relationship Between LRG and Periodontal Disease
|
N/A | |
Recruiting |
NCT03997578 -
Non-incised Papillae Surgical Approach (NIPSA) and Connective Tissue Graft Plus Emdogain for Periodontal Defects
|
N/A | |
Completed |
NCT03901066 -
Smoking Dependence and Periodontitis
|
||
Enrolling by invitation |
NCT04956211 -
Periodontal Treatment and Ischemic Stroke
|
N/A | |
Recruiting |
NCT05971706 -
Ozone Application in Periodontal Treatment
|
N/A | |
Recruiting |
NCT06099574 -
A Study on the Oral Health Status of Pregnant Women With Gestational Diabetes and Its Correlation With Oral Flora
|
||
Completed |
NCT04402996 -
Meteorin-like Levels in Individuals With Periodontitis
|
||
Active, not recruiting |
NCT05311657 -
Oral Health and Severe COPD
|
||
Not yet recruiting |
NCT06453278 -
(DDS) in India: a Screening Tool to Identify Prediabetes and Undiagnosed Type 2 Diabetes in Dental Settings
|
||
Not yet recruiting |
NCT05643287 -
The Effect of Time on the Outcome of Periodontal Treatment.
|
N/A |